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Abstract 
Fibroblasts prepared from the meninges of newborn mice or from mouse embryos, as well as fibroblast L929 cells, secreted an 
immunoreactive material (ir-kininogen) against rabbit anti-mouse low-molecular-weight kininogen antibody in response to dibutyryl 
CAMP. Western blots using a bradykinin-directed monoclonal, as well as a polyclonal anti-mouse low-molecular-weight kininogen 
antibody, showed that ir-kininogen had a molecular weight of 80000 and that it contained a kinin moiety. N-terminal amino acid 
sequence of the ir-kininogen was consistent with that of mouse L-kininogen. The ir-kininogen produced by fibroblasts released a kinin by 
incubating with trypsin and mouse submandibular gland kallikrein, and it was identified as bradykinin by means of high-performance 
liquid chromatography, indicating that mouse fibroblasts produce and secrete a kininogen. Forskolin, prostaglandin E, and tumor necrosis 
factor CY stimulated the production of ir-kininogen by meningeal fibroblasts, whereas neither dibutyryl CAMP nor these agents influenced 
kininogen production by mouse hepatocytes in primary cultures. These results demonstrated that fibroblasts are a source of kininogen in 
the mouse, and that it is regulated by the inflammatory mediators, prostaglandin E, and tumor necrosis factor. Therefore locally produced 
kininogen is implicated in pathogenesis of inflammation. 
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1. Introduction 
Kininogens are endogenous protein substrates for tissue 
and plasma kallikreins, which by proteolytic cleavage form 
vasoactive kinin peptides [ll. In addition, kininogens con- 
tain domains that function as cysteine proteinase inhibitors 
and act as cofactors for the contact activation of blood 
coagulation [l]. Three forms of kininogens have been 
identified in mammals: high-molecular-weight kininogen 
(H-kininogen), low-molecular-weight kininogen (L- 
kininogen) and T-kininogen [2]. We found a kininogen in 
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the ascitic fluid of tumor-bearing mice [3], and subse- 
quently identified it as mouse L-kininogen by analyzing 
aminoacid sequences and the susceptibility to glandular 
kallikreins [4]. 
It has been thought for many years that the source of 
kininogens is restricted to the liver. However, it has been 
demonstrated that L- or H-kininogen gene is expressed in 
human kidney or endothelial cells, respectively [5,6]. In the 
rat, T-kininogen gene is expressed in extrahepatic tissues 
including the lung, kidney, brain, and heart [7]. These lines 
of evidence suggest that the local tissues and organs 
independently synthesize kininogens. However, further ev- 
idence supporting this hypothesis has not been produced. 
Fibroblasts are ubiquitously distributed in several or- 
gans and tissues, and play a critical role in morphogenesis, 
dictating the structure of the skeleton, and organization of 
the skin [8]. When connective tissue sustains an injury, 
fibroblasts migrate to the site from neighboring connective 
tissue, where they proliferate, synthesize and remodel new 
matrix to repair the damage [9]. Thus, fibroblasts play an 
important role in the process of inflammatory reactions 
and tissue repair. To obtain evidence supporting the exis- 
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tence of a local kallikrein-kinin system, we studiedwhether 
or not mouse fibroblasts produce L-kininogen in vitro. The 
results demonstrated for the first time that mouse fibrob- 
lasts produce L-kininogen in response to dibutyryl CAMP 
(Bt2cAMP), forskolin, prostaglandin E, (PGE,) and tumor 
necrosis factor (Y (TNF). 
2. Materials and methods 
2.1. Materials 
The following chemicals were obtained from commer- 
cial sources: Bt2cAMP from Boehinger-Mannheim- 
Yamanouchi; forskolin, PGE,, trypsin (bovine pancreas) 
and kallikrein (porcine pancreas) from Sigma; horseradish 
peroxidase-labeled avidin and biotinylated goat anti-rabbit 
IgG from Bio-Rad; Immobilon-PSQ membrane from Milli- 
pore; protein A-agarose from Pierce; bradykinin and T- 
kinin from Peptide Institute (Osaka, Japan); Na[lz51] (94.3 
GBq/pmol) from American Radiolabeled Chemicals; 
Dulbecco’s modified Eagle’s medium (DMEM) from Nis- 
sui (Osaka, Japan); Williams’ medium E from ICN 
Biomedicals; rabbit anti-mouse fibronectin from Funakoshi 
(Tokyo, Japan); octadecyl disposable-column from J.T. 
Baker; recombinant mouse interleukin-6 (IL-6; 1 . 10’ 
U/mg) from Genzyme; L929 cells, Balb/3T3 clone A31 
(3T3) cells and SV40-transformed Balb/3T3 (SV40-3T3) 
cells from Dainippon Pharmaceutical, Osaka, Japan. Re- 
combinant human interleukin-la (IL-l; 2 . lo7 U/mg) 
and TNF (3 . lo6 U/mg) were donated by Dainippon 
Pharmaceutical (Osaka, Japan). The bradykinin-directed 
monoclonal antibody to kininogen was a gift from Dr. J. 
Chao, Department of Pharmacology, Medical University of 
South Carolina, Charleston, SC, USA. Mouse kallikrein 
was purified from submandibular glands as described pre- 
viously [3]. 
2.2. Ceil culture 
Fibroblasts were prepared from the meninges and the 
embryos of ICR mice as followed. The meninges were 
isolated from the hemispheres of l-day-old newborn mouse 
under a light microscope, incubated with 0.05% 
trypsin/0.02% EDTA for 2 min at 37°C then triturated 
using a Pasteur pipette. The suspended cells were washed 
twice with DMEM containing 5% fetal bovine serum 
(FBS), then filtered through a stainless steel net (mesh size 
of 150 pm). Cells in the filtrate were seeded in 90-mm 
culture dishes with DMEM supplemented with 5% FBS 
and 50 pg/ml of gentamycin (growth medium) and cul- 
tured at 37°C in humidified atmosphere of 95% air and 5% 
CO,. Embryonic fibroblast cultures were initiated from 
16-18-day-old decapitated and degutted embryos. The em- 
bryonic skin was washed with phosphate-buffered saline, 
pH 7.5, minced with scissors, then digested twice by 
stirring gently in 0.05% trypsin/0.02% EDTA for 5 min 
each. After washing and filtration, the cells were cultured 
as described above. After reaching confluence, cells were 
passaged by incubation with trypsin, and reseeded onto 
90-mm culture dishes. After reaching confluence again, the 
medium was replaced with FBS-free DMEM. These cul- 
tures contained mainly fibronectin-positive cells ( > 95%) 
when tested with rabbit antibody directed against mouse 
fibronectin. 
The mouse fibroblasts cell lines, L929, 3T3 and SV40- 
3T3 cells, were maintained in the growth medium as 
described above. Experiments were carried out at conflu- 
ence in FBS-free DMEM. 
Parenchymal hepatocytes were isolated from male ICR 
mice, weighing 35-40 g, by perfusing the liver with 
collagenase in situ, essentially as described by Seglen [lo]. 
The cells (2 . 105/well) were seeded in 24-well culture 
plates in 1 ml of Williams’ medium E supplemented with 
5% FBS, 10 nM insulin, 10 nM dexamethasone and 50 
pg/ml of gentamycin, and cultured at 37°C in 95% air 
and 5% CO,. The medium was replaced after the first 2 h 
of culture to remove unattached cells. After 24 h, cells 
were used for study. 
2.3. Radioimmunoassay of mouse kininogen 
Kininogen was determined by a radioimmunoassay us- 
ing ‘251-L-kininogen and rabbit anti-L-kininogen antibody, 
as described [3]. This assay detected 0.2 ng of L-kinino- 
gen. The intra-assay precision, as represented by the coef- 
ficient of variation of duplicates ranging throughout the 
standard curve, was &4.2%, and the inter-assay repro- 
ducibility was 5.3%. Cell protein levels were measured 
using the BCA protein Assay Reagent (Pierce). 
2.4. Western blots of kininogen 
Mouse meningeal or SV40-3T3 fibroblasts were cul- 
tured for 5 or 2 days, respectively, in FBS-free DMEM 
containing 1 mM Bt2cAMP or a combination of 1 mM 
Bt2cAMP and 1 PM dexamethasone, respectively, and the 
conditioned medium was harvested, dialyzed against dis- 
tilled water, then lyophilized. The lyophilized sample, 
together the conditioned medium of mouse hepatocytes; 
mouse serum and the ascitic fluid of Sarcoma 180 tumor- 
bearing mice, were resolved by sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis (SDS-PAGE) in a 10% 
gel according to the method of Laemmli [ll]. The resolved 
proteins were electrophoretically transferred to Immobilon- 
PSQ membrane [12], which was then blocked with 10% 
skim milk followed by incubation with rabbit anti-mouse 
L-kininogen or bradykinin-directed kininogen monoclonal 
antibody. Rabbit IgG or mouse IgG on the membrane was 
detected by means of chemiluminescent protein detection 
system (Immun-Lite II, Bio-Rad) using goat anti-rabbit or 
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anti-mouse IgG, respectively, according to the instruction 
manual provided with the kit. 
2.5. Assay and identification of kinin liberated from the 
conditioned medium of fibroblasts 
SV40-3T3 cells were cultured in FBS-free DMEM sup- 
plemented with 1 mM Bt2cAMP and 1 PM dexametha- 
sone for 2 days. The conditioned medium was dialyzed 
against distilled water and lyophilized. The lyophilized 
sample was dissolved in 0.1 M Tris-HCl, pH 8.0, contain- 
ing 2 mM o-phenanthroline, and an aliquot (1.8 pg) was 
incubated with kininogenases, such as bovine pancreas 
trypsin, porcine pancreas kallikrein, and mouse sub- 
mandibular gland kallikrein, at 37°C for 90 min. The 
reaction was terminated bsy heating in boiling water for 2 
min, and the liberated kinin was determined by means of 
the bradykinin radioimmunoassay using 125 I-Tyr-kallidin 
and rabbit anti-bradykinin antibody, as described previ- 
ously [3]. 
tein A-agarose [13]. The column was washed with 50 ml of 
20 mM Tris-HCl in 0.1 M NaCl (pH 8.0) and eluted with 
0.1 M glycine-HCl (pH 2.5). Fractions containing kinino- 
gen were pooled, dialyzed against distilled water, then 
lyophilized. The lyophilizate sample was resolved by 
SDS-PAGE, and proteins were transfered to Immobilon- 
PSQ membrane as described above, then stained by 
Coomassie brilliant blue. Membrane strip of the protein 
band was subjected to N-terminal sequence analysis. 
The N-terminal sequence of purified protein was deter- 
mined by automated Edman degradation on a pulsed-liquid 
sequencer (Model PPSQ-10, Shimazu, Kyoto, Japan) con- 
nected on line to an HPLC apparatus for PTH-amino acid 
identification. 
2.7. Statistical analysis 
Results are presented as mean f S.D. The statistical 
significance of the difference between means was deter- 
mined by Student’s t-test. 
The lyophilized sample described above was heated in 
boiling water for 3 min to inactivate kinin-destroying 
enzymes, then incubated with trypsin (200 pg/ml) in 50 
mM Tris-HCl, pH 8.0, for 2 h. The reaction was termi- 
nated by adding trifluoroacetic acid (TFA) at a final 
concentration of 30%, and the mixture was applied to an 
octadecyl extraction-column (3-ml bed volume), primed 
with methanol followed by 1% TFA. The column was 
washed 3 times with 5 mll of 0.1% TFA, then eluted with 
90% methanol containing 0.1% TFA. The eluate was 
evaporated, and the residue was dissolved in 40 mM 
triethylamine-formate, pH 4.0, then analyzed by reverse- 
phase high-performance liquid chromatography (HPLC) 
(model 880-PU; Japan Spectroscopic), using an octadecyl 
column (Biofine RPCSCIl8B), equilibrated with a mixture 
of 40 mM triethylamine-formate (pH 4.0) and acetonitrile 
(81/19) [2]. Kinin was isocratically eluted with the same 
solvent at a flow rate of 0.8 ml/min, and 1-min fractions 
were collected. After evaiporating the solvent from each 
fraction, the kinin levels were determined by the kinin 
radioimmunoassay. A mixture contaning 0.5 pg each of 
standard bradykinin and ‘T-kinin (ile-ser-bradykinin) was 
analyzed by HPLC under the same conditions. 
3. Results 
3.1. Mouse fibroblasts secreted kininogen-like material 
Kininogen radioimmunoassay using anti-mouse L- 
kininogen antibody revealed that the conditioned media of 
mouse meningeal, embryonic, L929 and SV40-3T3 fibrob- 
lasts contained kininogen-like immunoreactive material 
(ir-kininogen). The conditioned medium of meningeal, em- 
bryonic or L929 fibroblasts cultured for 5 days contained 
35.2, 9.2 or 6.9 ng/mg cell protein (n = 3), respectively, 
and that of SV40-3T3 cells after 2 days contained 117 
ng/mg (n = 3). We could not detect ir-kininogen in the 
conditioned medium of 3T3 cells, the parent line of the 
SV40-3T3 cells, within the detection limit of the L- 
kininogen radioimmunoassay. 
3.2. Effects of Bt2cAMP, forskolin and dexamethasone on 
the secretion of ir-kininogen by mouse fibroblasts 
2.6. Purification and N-terminal amino acid sequence 
analysis of kininogen from conditioned medium of mouse 
fibroblasts 
The ir-kininogen secreted by meningeal or L929 fibrob- 
lasts was stimulated by 1 mM Bt2cAMP, and by forskolin 
(10 PM), an activator of adenylate cyclase, for at least 5 
days (Fig. l), in a dose-dependent manner (data not shown). 
Bt2cAMP also stimulated the secretion of ir-kininogen by 
embryonic fibroblasts (data not shown). 
Meningeal fibroblasts were cultured in FBS-free DMEM When the conditioned medium of BQcAMP-stimulated 
containing 1 mM Bt2cAMP for 5 days, and the condi- meningeal or L929 fibroblasts was concentrated by lyoph- 
tioned medium (500 ml) was dialyzed against distilled ilization and assayed by kininogen radioimmunoassay, the 
water, then lyophilized. The lyophilizate sample was dis- displacement of ‘251-L-kininogen binding to antibody by 
solved in 5 ml of 20 mh4 Tris-HCl in 0.1 M NaCl (pH various concentrations of lyophilized sample paralleled 
8.0), then centrifuged at 3000 X g for 5 min. The super- that by standard L-kininogen (data not shown). 
natant was applied to a column (2-ml bed volume) of Dexamethasone (1 PM) alone did not influence the 
rabbit anti-mouse L-kininogen IgG cross-linked with pro- basal secretion of irL-kininongen by meningeal and L929 
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Fig. 1. The effect of Bt2cAMP and forskolin upon the secretion of 
ir-kininogen by mouse meningeal and L929 fibroblasts. Fibroblasts were 
cultured for 1, 3 and 5 days under basal conditions (0) or in the presence 
of 1 mM Bt2cAMP (0) or 10 PM forskolin (A). The level of ir- 
kininogen in the conditioned medium was determined by kininogen 
radioimmunoassay. The results are expressed as the means&SD. of 
ir-kininogen/mg cell protein of 4 wells. Statistical analyses in compari- 
son to unstimulated culture: * P < 0.05, * * P < 0.01, * * * P < 0.001. 
fibroblasts, whereas it inhibited the Bt2cAMP-induced se- 
cretion of ir-kininogen by 70% in meningeal fibroblasts or 
by 86% in L929 cells (Fig. 2). In contrast, ir-kininogen 
secretion by SV40-3T3 cells was not affected by Bt2cAMP 
alone, but was markedly stimulated by the addition of both 
1 mM Bt2cAMP and 1 PM dexamethasone (Fig. 2). 
3.3. Western blots of ir-kininogen secreted by mouse fi- 
broblasts 
To characterize ir-kininogen, meningeal or SV40-3T3 
fibroblasts were cultured for 5 or 2 days in the presence of 
Bt2cAMP or a combination of Bt2cAMP and dexametha- 
sone, respectively, and the conditioned media were 
lyophilized. These samples, together with purified mouse 
L-kininogen, ascitic fluid of Sarcoma 180 tumor-bearing 
mouse, mouse serum and conditioned medium of mouse 
hepatocytes in primary culture, were resolved by SDS- 
PAGE, and the immunoreactivity was localized following 
Western blotting using rabbit anti-L-kininogen antibody. 
At least two major bands with molecular weights of about 
80 000 and 67 000 were detected in ascitic fluid, serum and 
conditioned medium of hepatocytes, and the mobility of 
the band with a molecular mass of 67000 corresponded to 
that of purified L-kininogen (Fig. 3). The conditioned 
medium of meningeal or SV40-3T3 fibroblasts showed 
virtually a single band, with a molecular weight that was 
slightly higher than that of purified L-kininogen and which 
corresponded to an immunoreactive band with a molecular 
weight of 80000 in ascitic fluid, serum or conditioned 
medium of hepatocytes (Fig. 3). 
When the immunoreactivity on the blot was localized 
by the bradykinin-directed monoclonal antibody for 
kininogens, an immunoreactive band with a molecular 
weight of 80000 was found in the conditioned medium of 
either meningeal or SV40-3T3 fibroblasts, as well as in 
that of mouse hepatocytes (Fig. 3). There was also a faint 
band corresponding to a molecular weight of 67 000 in the 
conditioned medium of hepatocytes. 
3.4. N-terminal amino acid sequence of ir-kininogen puri- 
fied from the conditioned medium of mouse fibroblasts 
N-terminal amino acid sequence (30-residues) of ir- 
kininogen, which was purified from the conditioned 
medium of meningeal fibroblasts by an immunoaffinity 
chromatography followed by SDS-PAGE, was EEAQEID- 
CNDEAVFQAVDFSLKQFNPGVKS that corresponded to 
N-terminal sequence of mouse L-kininogen purified from 
ascitic fluid [4]. 
3.5. Kinin liberation by trypsin and kallikreins from the 
conditioned medium of SV40-3T3 cells 
Mouse L-kininogen liberates bradykinin upon exposure 
to trypsin or mouse submandibular gland kallikrein, 
whereas it is relatively unsusceptible to tissue kallikreins 
of other species, such as porcine pancreatic and rat urinary 
kallikreins [3,4]. To further characterize ir-kininogen, the 
conditioned medium of SV40-3T3 cells was lyophilized, 
then incubated with trypsin, porcine pancreatic kallikrein 
and mouse submandibular gland kallikrein. As shown in 
Fig. 4, the conditioned medium liberated a kinin, that was 
determined by bradykinin radioimmunoassay, upon incuba- 
tion with trypsin and mouse submandibular gland 
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Fig. 2. The effects of Bt2cAMP and dexamethasone on the secretion of 
ir-kininogen by meningeal, L929 and SV4-3T3 fibroblasts. Fibroblasts 
were cultured for 5 (meningeal and L929 cells) or 2 days (SV40-3T3 
cells) under basal conditions, or with 1 mM BQcAMP, 1 PM dexametha- 
sone or a combination of these. The level of ir-kininogen in the condi- 
tioned medium was determined by radioimmunoassay. The results are 
expressed as the means + S.D. of ir-kininogen/mg cell protein of 4 wells. 
Statistical analyses in comparison to unstimulated culture: * * P < 0.01, 
“‘P<0.001. 
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Fig. 3. Western blots of ir-kininogen secreted by mouse fibroblasts. 
Meningeal or SV40-3T3 fibroblasts were cultured with 1 mM Bt2cAMP 
for 5 days or with a combination of 1 mM Bt2cAMP and 1 PM 
dexamethasone for 2 days, reslpectively. The conditioned medium was 
concentrated, and aliquots (100 ng ir-kininogen of meningeal fibroblasts 
and 25 ng ir-kininogen of SV40-3T3 cells) were separated by SDS-PAGE 
and electrophoretically transferred to a nitrocellulose membrane. Purified 
mouse Gkininogen, ascitic fluid of Sarcoma 180 tumor-bearing mouse, 
mouse serum, and conditioned medium of mouse hepatocytes in primary 
culture were also resolved (100 ng kininogen/lane). The blot was 
incubated with anti-L-kininogen antibody (panel A) or bradykinin-di- 
rected anti-kininogen monoclonal antibody (panel B) followed by detec- 
tion with Bio-Rad Immun-Lite I[. (A) Lane 1, L-kininogen; lane 2, ascitic 
fluid; lane 3, serum; lane 4, conditioned medium of mouse hepatocytes; 
lane 5, conditioned medium of SV40-3T3 cells; lane 6, conditioned 
medium of meningeal fibroblasts. (B) Lane 1, L-kininogen; lane 2, ascitic 
fluid; lane 3, conditioned meclium of mouse hepatocytes in primary 
culture; lane 4, conditioned medium of SV40-3T3 cells; lane 5, condi- 
tioned medium of meningeal fibroblasts. 
kallikrein, whereas it liberated less in the presence of 
porcine kallikrein. The kinin liberated by trypsin was 
eluted from reverse-phase HPLC as a single peak with the 
Mouse 
kallikrein 
Porcine 
kallikrein 
0 10 20 
Kinin (ng bradykinin equiv. / assay) 
Fig. 4. Kinin liberation from ir-kininogen by incubation with trypsin and 
kallikreins. SV40-3T3 cells were cultured for 2 days with 1 mM Bt2cAMP 
and 1 PM dexamethasone, then the conditioned medium was lyophilized. 
The lyophilized material containing 1.8 pg of ir-kininogen was incubated 
with trypsin and kallikreins at pH 8.0 for 90 min, and the amount of kinin 
generated was determined by a bradykinin radioimmunoassay. The values 
represent the means of two determinations. 
same retention time as that of a bradykinin standard eluted 
from the same column under identical conditions (data not 
shown). 
3.6. Effects of PGE,, TNF, IL-l and IL-6 on the secretion 
of ir-kininogen by meningeal and L929 fibroblasts 
The fact that both Bt2cAMP and forskolin stimulated 
the secretion of ir-kininogen by mouse fibroblasts sug- 
gested that elevated intracellular CAMP levels triggered 
ir-kininogen production in fibroblasts. To confirm this 
notion, we studied the effect of PGE,, which stimulates 
CAMP synthesis in fibroblasts [14], on the secretion of 
ir-kininogen by fibroblasts. As shown in Fig. 5, 10 PM 
PGE, did not affect the secretion of ir-kininogen by 
meningeal and L929 fibroblasts within 24 h, but signifi- 
cantly stimulated it after 24 h. A lower concentration (0.1 
PM) of PGE, also stimulated L929 cells. 
Meningeal fibroblasts L929 cells 
-7-J *** I 
0 1 2 3 0 i i 3 
Time (days) Tit-w (days) 
Fig. 5. The effect of PGE, on the secretion of ir-kininogen by mouse 
meningeal and L929 fibroblasts. Fibroblasts were cultured for 3 days 
under basal conditions (0) or in the presence of PGE, at 0.1 PM (A) 
and 10 PM (0). Th e eve s o Ir mono 1 1 f -k’ g en in the conditioned medium 
was determined by kininogen radioimmunoassay. The results are ex- 
pressed as the means + S.D. of ir-kininogen/mg cell protein of 4 wells. 
Statistical analyses in comparison to unstimulated culture: * P < 0.05, 
* * P < 0.01, * * * P < 0.001. 
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Fig. 6. The effects of cytokines on the secretion of ir-kininogen by mouse 
meningeal fibroblasts. Meningeal fibroblasts were cultured for 3 days in 
the presence of TNF, IL-1 and IL-6 at the indicated concentrations. The 
level of ir-kininogen in the conditioned medium was determined by 
kininogen radioimmunoassay. The results shows % of basal secretion and 
are expressed as the means+S.D. of 4 wells. Statistical analyses in 
comparison to unstimulated culture: ’ * P < 0.01. 
Since cytokines such as TNF and IL-l increase PGE, 
synthesis in mouse fibroblasts, which in turn stimulates 
CAMP synthesis [15,16], we studied the effect of these 
cytokines on the secretion of ir-kininogen by fibroblasts. 
The secretion of ir-kininogen by meningeal fibroblasts was 
stimulated by TNF (5-500 U/ml), but not by IL-l or IL-6 
at a concentration of 500 U/ml (Fig. 6). 
3.7, Effects of BT2cAMP, PGEz, TNF and IL-6 on the 
secretion of kininogen by mouse hepatocytes 
Mouse hepatocytes secreted 1.03 + 0.18 pg kinino- 
gen/mg cell protein after 2 days in culture (mean f SD. 
of 4 wells), as measured by kininogen radioimmunoassay, 
and the secretion was not altered by Bt2cAMP (1 mM), 
PGE, (10 PM), TNF (500 U/ml), IL-l (500 U/ml) and 
11-6 (500 U/ml) (data not shown). 
4. Discussion 
Mouse L-kininogen was first isolated as a cysteine 
proteinase inhibitor from the ascitic fluid of the Sarcoma 
180 tumor-bearing mouse and subsequently characterized 
as L-kininogen [3,4]. It has a highly homologous structure 
to other mammalian L-kininogens and releases bradykinin 
upon exposure to trypsin and mouse submandibular gland 
kallikrein, but is relatively unsusceptible to kallikreins of 
other species, which probably due to a unique -Met-Ala- 
Arg-bradykinin sequence [3,4]. We investigated two pri- 
mary cultures (meningeal and embryonic) and three cell 
lines (L929, 3T3 and SV40-transformed 3T3) of mouse 
fibroblasts to determine whether fibroblasts produced 
kininogen. Except for 3T3 cells, all fibroblasts secreted 
ir-kininogen during culture, though the levels were very 
low as compared to that by mouse hepatocytes. Western 
blotting using anti-L-kininogen antibody revealed that the 
molecular weight of ir-kininogen secreted by mouse 
meningeal or SV40-3T3 fibroblasts was slightly higher 
than that of L-kininogen. A similar protein was also pre- 
sent in ascitic fluid, serum and conditioned medium of 
cultured hepatocytes. A monoclonal antibody against 
bradykinin moiety of kininogens recognized the same 
molecule in the conditioned medium of fibroblasts, as well 
as in that of cultured hepatocytes, indicating that the 
ir-kininogen contains bradykinin sequence. This was con- 
firmed by findings that trypsin and mouse submandibular 
gland kallikrein liberated kinin from fibroblast-conditioned 
medium, but that porcine kallikrein had little effect. Fur- 
thermore, N-terminal amino acid sequence (30 residues) in 
kininogen secreted from meningeal fibroblasts was the 
same in mouse L-kininogen. Thus, mouse fibroblasts se- 
crete a kininogen that is indistinguishable from L-kinino- 
gen with respect to immunoreactivity, susceptibility to 
tissue kallikreins and N-terminal structure. However, we 
cannot exclude a possibility that a polyclonal antibody to 
mouse L-kininogen used in this study recognized H- 
kininogen as well as L-kininogen, since a heavy chain at 
the amino-terminus of kininogen, a large portion of kinino- 
gen structure, is identical in L- and H-kininogens [l]. 
Therefore, further study is required to determine the rela- 
tionship between the 80 kDa-kininogen derived from fi- 
broblasts and L- or H-kininogen in plasma, especially with 
regard to their structures of light-chains. 
The kininogen production by fibroblasts, except for 
SV40-3T3 cells, was markedly stimulated by Bt2cAMP 
and forskolin, suggesting that the elevation of intracellular 
CAMP triggers an induction of kininogen synthesis in 
fibroblasts. Bt2cAMP-induced kininogen production was 
inhibited by a low concentration of dexamethasone. In 
contrast, kininogen production by SV40-3T3 cells was not 
altered by Bt2cAMP alone but was stimulated with a 
combination of Bt2cAMP and dexamethasone. Why the 
responsiveness of SV40-3T3 cells to dexamethasone dif- 
fers from that of other fibroblasts is unknown, but it is 
possible that a signal transduction pathway in the CAMP- 
dependent regulation of ir-kininogen expression is altered 
in the transformed cells. 
We found that PGE, and TNF stimulated kininogen 
production by mouse fibroblasts. Since PGE, potently 
stimulates intracellular CAMP levels [14], it is likely that 
the effect is mediated by CAMP. Burch et al. have reported 
that TNF stimulates PGE, synthesis in mouse fibroblasts, 
which in turn, stimulates CAMP accumulation [15], sug- 
gesting that the effect of TNF on kininogen production is 
secondary to PGE, release. However, IL-l, which also 
elevates intracellular CAMP levels in fibroblasts via stimu- 
lating PGE, synthesis [16], did not influence kininogen 
production. The precise mechanisms by which TNF stimu- 
lates kininogen production in fibroblasts remain to be 
determined. 
PGE, and TNF are produced at sites of inflammation 
and play important roles in its pathogenesis [17,18]. These 
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inflammatory mediators stimulated kininogen production 
by fibroblasts, suggesting that kininogen production is 
enhanced in the connective tissues during inflammation, 
therefore implying the involvement of kininogen in the 
generation and maintenance of such conditions. The fact 
that neither these inflammatory mediators nor CAMP- 
elevating agents influenced kininogen production by mouse 
hepatocytes may support this hypothesis. Kininogens are 
endogenous substrates for plasma and tissue kallikreins by 
which kinins are released. Kinins are important mediators 
of inflammation, producing vasodilatation, increased vas- 
cular permeability, leukotaxis and pain [19]. Tissue 
kallikreins are found in salivary, pancreas, pituitary and 
mucous/serous secreting glands [20,21]. A kallikrein-like 
enzyme has also been identified in basophils and mast 
cells [22]. Figueroa et al. have demonstrated that tissue 
kallikrein is present in th’e intracellular granules of human 
neutrophils that release k.allidin from human L-kininogen 
[23]. Their findings suggested that neutrophils which accu- 
mulate at sites of inflammatory reactions, release tissue 
kallikrein by degranulation or secretion. This in turn, 
generates kinins from L-kininogen. These lines of evidence 
suggest that PGE, or TNF released from fibroblasts them- 
selves, as well as from neutrophils, macrophages and 
lymphocytes [17,18] at the site of inflammation, triggers 
the induction of kininogen production by fibroblasts, 
thereby releasing kinins by the action of kallikreins that 
derive from the circulation or are produced at local tissues. 
Like interactions involving cells in inflammation, there 
seems to be complex intleractions between the generation 
of kinins and other inflammatory mediators. PGE, and 
TNF may enhance kinin generation via the stimulation of 
kininogen production, then the released kinin stimulates 
PGE, release from fibroblasts and other cells [19] and 
TNF release from macrophages [24]. Such amplification by 
positive feedback loops may be an important mechanism 
in maintaining chronic inflammation. This may be true of 
rheumatoid arthritis where prostaglandins, cytokines and 
kinins are present [l&25.,26]. Further studies are required 
to confirm this hyothesis. 
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